Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	CAPN9 LPCAT1 CLGN TRPM2 BNIP2 HMCN2 UMODL1 PLCB3 FER1L5 PNLIPRP2 CANX CAPN3 DUOX2 TTYH3 RET GSN SLC8A1 HMCN1 VCAN PITPNM3 CDH1 CDH2 CDH8 RASGRP2	9.85e-06	749	236	24	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CHL1 HMCN2 NRCAM ESAM RET HMCN1 IGSF9B CDH1 CDH2 PALLD CDH8	9.22e-06	187	232	11	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CHL1 HMCN2 UNC5D NRCAM ESAM APOA1 RET HMCN1 ARVCF IGSF9B CDH1 CDH2 PALLD CDH8	1.33e-05	313	232	14	GO:0098742
GeneOntologyCellularComponent	axon	MYC MYO1D FRMD7 NFASC PTCH1 ATAT1 BLVRB CDKL5 HMCN2 USH2A CNGB1 PNOC SLC4A8 NRCAM SEPTIN4 CANX ATCAY RET SLC8A1 AP3B2 SLC4A10 WDFY3 CDH1 PALLD CDH8	3.43e-05	891	239	25	GO:0030424
GeneOntologyCellularComponent	neuron projection terminus	BLVRB USH2A CNGB1 PNOC SLC4A8 SEPTIN4 ATCAY SLC8A1 SLC4A10 CDH1 CDH8	8.12e-05	233	239	11	GO:0044306
GeneOntologyCellularComponent	distal axon	FRMD7 PTCH1 BLVRB CDKL5 USH2A CNGB1 PNOC SLC4A8 SEPTIN4 ATCAY SLC8A1 SLC4A10 CDH1 PALLD CDH8	1.56e-04	435	239	15	GO:0150034
GeneOntologyCellularComponent	axon terminus	BLVRB USH2A CNGB1 PNOC SLC4A8 SEPTIN4 SLC8A1 SLC4A10 CDH1 CDH8	1.59e-04	210	239	10	GO:0043679
GeneOntologyCellularComponent	somatodendritic compartment	CHL1 MYO1D FRMD7 TRPM2 ADGRB1 NFASC PTCH1 GPR179 CDKL5 BPTF HMCN2 USH2A PLK3 PNOC SLC4A8 SEPTIN4 CANX ATCAY MAGOHB RET SHANK3 SLC8A1 SLC4A10 ASTN1 IGSF9B WDFY3 PALLD CYBA	3.95e-04	1228	239	28	GO:0036477
Domain	FN3	CHL1 EPOR OBSCN IL20RA NFASC UMODL1 USH2A NRCAM IGDCC3 CSF3R ASTN1 IGSF9B LRRN4	1.35e-06	199	233	13	PS50853
Domain	FN3_dom	CHL1 EPOR OBSCN IL20RA NFASC UMODL1 USH2A NRCAM IGDCC3 CSF3R ASTN1 IGSF9B LRRN4	2.34e-06	209	233	13	IPR003961
Domain	FN3	CHL1 EPOR OBSCN NFASC UMODL1 USH2A NRCAM IGDCC3 CSF3R ASTN1 IGSF9B LRRN4	3.74e-06	185	233	12	SM00060
Domain	fn3	CHL1 EPOR OBSCN NFASC UMODL1 USH2A NRCAM IGDCC3 CSF3R IGSF9B LRRN4	6.16e-06	162	233	11	PF00041
Domain	Neurofascin/L1/NrCAM_C	CHL1 NFASC NRCAM	7.60e-06	4	233	3	IPR026966
Domain	Bravo_FIGEY	CHL1 NFASC NRCAM	7.60e-06	4	233	3	PF13882
Domain	Ig-like_fold	CHL1 EPOR PDCD1 LILRB2 OBSCN IL20RA NFASC HMCN2 UMODL1 ADGRF3 USH2A TREML1 UNC5D NRCAM IGDCC3 ESAM HMCN1 CSF3R VCAN ASTN1 IGSF9B LRRN4 IGSF1 PALLD	8.91e-06	706	233	24	IPR013783
Domain	Ig_I-set	CHL1 OBSCN NFASC HMCN2 UNC5D NRCAM IGDCC3 ESAM HMCN1 IGSF9B PALLD	2.76e-05	190	233	11	IPR013098
Domain	I-set	CHL1 OBSCN NFASC HMCN2 UNC5D NRCAM IGDCC3 ESAM HMCN1 IGSF9B PALLD	2.76e-05	190	233	11	PF07679
Domain	IGc2	CHL1 OBSCN NFASC HMCN2 UNC5D NRCAM IGDCC3 ESAM HMCN1 IGSF9B IGSF1 PALLD	4.13e-05	235	233	12	SM00408
Domain	Ig_sub2	CHL1 OBSCN NFASC HMCN2 UNC5D NRCAM IGDCC3 ESAM HMCN1 IGSF9B IGSF1 PALLD	4.13e-05	235	233	12	IPR003598
Domain	IG	CHL1 PDCD1 LILRB2 OBSCN NFASC HMCN2 TREML1 UNC5D NRCAM IGDCC3 ESAM HMCN1 VCAN IGSF9B IGSF1 PALLD	8.24e-05	421	233	16	SM00409
Domain	Ig_sub	CHL1 PDCD1 LILRB2 OBSCN NFASC HMCN2 TREML1 UNC5D NRCAM IGDCC3 ESAM HMCN1 VCAN IGSF9B IGSF1 PALLD	8.24e-05	421	233	16	IPR003599
Domain	-	CHL1 EPOR PDCD1 OBSCN IL20RA NFASC UMODL1 USH2A TREML1 UNC5D NRCAM IGDCC3 ESAM HMCN1 CSF3R VCAN ASTN1 IGSF9B LRRN4 IGSF1 PALLD	9.12e-05	663	233	21	2.60.40.10
Domain	Ig-like_dom	CHL1 PDCD1 LILRB2 OBSCN NFASC HMCN2 TREML1 UNC5D NRCAM IGDCC3 ESAM HMCN1 CSF3R VCAN IGSF9B IGSF1 PALLD	2.03e-04	503	233	17	IPR007110
Domain	GPCR_2_brain_angio_inhib	ADGRB1 ADGRB2	4.61e-04	3	233	2	IPR008077
Domain	-	CLGN CANX	4.61e-04	3	233	2	2.10.250.10
Domain	CALRETICULIN_REPEAT	CLGN CANX	4.61e-04	3	233	2	PS00805
Domain	IG_LIKE	CHL1 PDCD1 LILRB2 OBSCN NFASC HMCN2 TREML1 UNC5D NRCAM IGDCC3 ESAM HMCN1 VCAN IGSF9B IGSF1 PALLD	4.66e-04	491	233	16	PS50835
Domain	NPIP	NPIPB15 NPIPB9 NPIPB8	6.30e-04	14	233	3	IPR009443
Domain	G2F	HMCN2 HMCN1	9.15e-04	4	233	2	PF07474
Domain	Myc_N	MYC MYCL	9.15e-04	4	233	2	PF01056
Domain	Bcl2-/adenovirus-E1B	BNIP2 ATCAY	9.15e-04	4	233	2	IPR022181
Domain	NIDOGEN_G2	HMCN2 HMCN1	9.15e-04	4	233	2	PS50993
Domain	Calret/calnex	CLGN CANX	9.15e-04	4	233	2	IPR001580
Domain	Tscrpt_reg_Myc_N	MYC MYCL	9.15e-04	4	233	2	IPR012682
Domain	Tscrpt_reg_Myc	MYC MYCL	9.15e-04	4	233	2	IPR002418
Domain	GFP	HMCN2 HMCN1	9.15e-04	4	233	2	IPR009017
Domain	CALRETICULIN_1	CLGN CANX	9.15e-04	4	233	2	PS00803
Domain	CALRETICULIN_2	CLGN CANX	9.15e-04	4	233	2	PS00804
Domain	Calret/calnex_CS	CLGN CANX	9.15e-04	4	233	2	IPR018124
Domain	BNIP2	BNIP2 ATCAY	9.15e-04	4	233	2	PF12496
Domain	Prot_disulphide_isomerase	PDIA2 PDIA4	9.15e-04	4	233	2	IPR005792
Domain	Calreticulin	CLGN CANX	9.15e-04	4	233	2	PF00262
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	9.15e-04	4	233	2	IPR006605
Domain	TSP_1	ADGRB1 ADGRB2 UNC5D HMCN1 ADAMTS7	1.13e-03	63	233	5	PF00090
Domain	-	CLGN USH2A CANX LAMA4 NBEA WDFY3	1.22e-03	95	233	6	2.60.120.200
Domain	TSP1	ADGRB1 ADGRB2 UNC5D HMCN1 ADAMTS7	1.30e-03	65	233	5	SM00209
Domain	TSP1_rpt	ADGRB1 ADGRB2 UNC5D HMCN1 ADAMTS7	1.30e-03	65	233	5	IPR000884
Domain	TSP1	ADGRB1 ADGRB2 UNC5D HMCN1 ADAMTS7	1.30e-03	65	233	5	PS50092
Domain	Na/HCO3_transpt	SLC4A8 SLC4A10	1.51e-03	5	233	2	IPR003024
Domain	Calreticulin/calnexin_P_dom	CLGN CANX	1.51e-03	5	233	2	IPR009033
Domain	DUF4704	NBEA WDFY3	1.51e-03	5	233	2	IPR031570
Domain	DUF4704	NBEA WDFY3	1.51e-03	5	233	2	PF15787
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K	EPOR JAK2 PIK3CG GAB1	1.17e-05	12	180	4	M27905
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K	EPOR JAK2 PIK3CG GAB1	1.17e-05	12	180	4	MM15623
Pathway	REACTOME_SIGNALING_BY_ERYTHROPOIETIN	EPOR JAK2 PIK3CG GAB1	5.37e-05	17	180	4	MM15584
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCL SRXN1 SPIRE2 INTS1 OBSCN ADGRB2 IRAK1 PTCH1 CNTROB ESRP2 JAK2 PLK3 PKN3 RIC1 PRRC2B SH3RF1 SZT2 POMGNT1 TTYH3 MED13L C6orf132 MICALL1 ADAMTS7 ARVCF PLEKHO2 WDFY3 CABIN1	2.38e-08	1105	245	27	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK ADGRB2 NFASC ERBIN DDX3X FAM120A CAMSAP2 PRRC2B MYBBP1A DNAJC13 SLC4A8 NRCAM ZNF618 CANX NBEA PREPL SHANK3 GSN NOSIP ARVCF SMARCC1 WDFY3 CABIN1 CDH2 KDM1A	2.55e-08	963	245	25	28671696
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ERBIN GTF3C4 PASK BPTF PLCB3 UNC5D ARHGEF6 MYBBP1A DNAJC13 UBA2 LARP1 CHAMP1 PNISR MICALL1 PCF11 SETD2 FHOD1 SMARCC1 YY1AP1 EIF3B ZMYM3 CDK2	3.83e-08	774	245	22	15302935
Pubmed	The Erbin PDZ domain binds with high affinity and specificity to the carboxyl termini of delta-catenin and ARVCF.	ERBIN ARVCF CDH1 CDH2	1.65e-07	8	245	4	11821434
Pubmed	Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase.	PIK3CG CDH1 CDH2	3.45e-07	3	245	3	17646933
Pubmed	Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer.	CDH1 CDH2 KDM1A	3.45e-07	3	245	3	23314859
Pubmed	LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.	CDH1 CDH2 KDM1A	3.45e-07	3	245	3	23900215
Pubmed	Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.	CHL1 SALL3 PTCH1 MMP2 TCF21 SLC26A2 APOA1 RET CBS MSX1 ARVCF CDH1 CDH2	7.67e-07	331	245	13	20634891
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK IRAK1 SPART ERBIN GTF3C4 DDX3X CAMSAP2 PKN3 PRRC2B MYBBP1A AHCTF1 ATG2B LARP1 PRPF8 CHAMP1 CBS SETD2 IARS2 FHOD1 SUGP1 PALLD CDK2	9.31e-07	934	245	22	33916271
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	SPAG1 MYO1D ASPM ZNF618 CANX CAPN3 XPNPEP1 PDIA4 IARS2 PLEKHO2 FHOD1 ASB2	1.11e-06	288	245	12	38496616
Pubmed	The armadillo repeat region targets ARVCF to cadherin-based cellular junctions.	ARVCF CDH1 CDH2	1.37e-06	4	245	3	11058098
Pubmed	mARVCF cellular localisation and binding to cadherins is influenced by the cellular context but not by alternative splicing.	ARVCF CDH1 CDH2	1.37e-06	4	245	3	11719554
Pubmed	Structural and functional evolution of the L1 family: are four adhesion molecules better than one?	CHL1 NFASC NRCAM	1.37e-06	4	245	3	10662501
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNIK ERBIN PASK FAM120A OTULIN CAMSAP2 ATG2B PRMT3 PALLD GAB1	2.59e-06	209	245	10	36779422
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DIS3L CEP68 AHRR FAM120A RIC1 SLC4A8 SH3RF1 ZNF618 DGKD TTYH3 SHANK3 PCF11 SETD2 SPIDR PALLD	2.63e-06	493	245	15	15368895
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SPAG1 IRAK1 ERBIN DDX3X DDX6 CDKL5 FMN1 PLCB3 SH3RF1 LARP1 C6orf132 MICALL1 ARVCF PLEKHO2 CDH1 GAB1	3.06e-06	565	245	16	25468996
Pubmed	NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transition.	SMARCC1 CDH1 CDH2	3.42e-06	5	245	3	26257059
Pubmed	Human transcription factor protein interaction networks.	MYC BRIX1 MYO1D DIS3L IRAK1 GON4L ERBIN BPTF FAM120A MRPL24 PRRC2B MYBBP1A CANX LARP1 MORC4 RBM20 NOSIP PCF11 PDIA4 SUGP1 SMARCC1 YY1AP1 EIF3B LAS1L CABIN1 ZMYM3 KDM1A	3.55e-06	1429	245	27	35140242
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BRIX1 MYO1D INTS1 BPTF FAM120A PRRC2B MYBBP1A AHCTF1 CANX LARP1 PRPF8 PDIA4 IARS2 SMARCC1 LAS1L ZMYM3 KDM1A	4.58e-06	653	245	17	22586326
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	MYC GTF3C4 FANCG RAMAC HUS1 GPX8 FANCL DCLRE1B MED13L CHAMP1 NOSIP SETD2 SMARCC1 CABIN1	4.77e-06	453	245	14	29656893
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MYO1D SPART ASPM PRRC2B SH3RF1 PPM1D CANX UBA2 MORC4 RBM20 NOSIP SETD2 YY1AP1 ZMYM3 KDM1A GAB1	5.06e-06	588	245	16	38580884
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TNIK SPART CEP68 JMJD6 KATNIP PRRC2B KDM1A	1.00e-05	105	245	7	9628581
Pubmed	Stabilized beta-catenin in thymic epithelial cells blocks thymus development and function.	CIITA MSX1 CDH1 CDH2	1.07e-05	20	245	4	19234195
Pubmed	EphB regulates L1 phosphorylation during retinocollicular mapping.	CHL1 NFASC NRCAM	1.18e-05	7	245	3	22579729
Pubmed	Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors.	MYC MYCL PTCH1	1.18e-05	7	245	3	12441288
Pubmed	Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant.	MYC CDH1 GAB1	1.18e-05	7	245	3	12095915
Pubmed	Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors.	EPOR JAK2 GAB1	1.18e-05	7	245	3	14982882
Pubmed	Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.	MMP2 ENOSF1 RET CBS CYBA	1.29e-05	43	245	5	20565774
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	IRAK1 SPART ERBIN DDX3X DDX6 MYBBP1A SH3RF1 AHCTF1 CANX ATG2B LARP1 ABCC5 XPNPEP1 MICALL1 PDIA4 PALLD GAB1	1.31e-05	708	245	17	39231216
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	DDX3X DDX6 BPTF FAM120A PLAGL2 PRRC2B MAGOHB UBA2 LARP1 DPP3 MED13L GSN NOSIP PCF11 PDIA4 SUGP1 SMARCC1 CDCA5 ZMYM3 KDM1A CDK2 RASGRP2	1.31e-05	1103	245	22	34189442
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	TNIK ADGRB2 NFASC ERBIN CDKL5 STARD9 CAMSAP2 LARP1 SHANK3 VCAN AP3B2 TMOD1 CDH2	1.32e-05	430	245	13	32581705
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADGRB1 ADGRB2 MMP2 HMCN1 ADAMTS7 CDH1	1.54e-05	75	245	6	20637190
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYC LPCAT1 DIS3L IRAK1 PASK BPTF FAM120A HMCN2 JMJD6 ASPM UNC5D PRRC2B P3H3 ZNF618 AHCTF1 TAF1C CHAMP1 SETD2 SMARCC1 WDFY3 ZMYM3 KDM1A	1.57e-05	1116	245	22	31753913
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	MYC LPCAT1 INTS1 NFASC GTF3C4 RETREG3 MRC2 UGT8 TMEM97 MYBBP1A DNAJC13 GPX8 AHCTF1 CANX TTYH3 DCLRE1B PRPF8 CHAMP1 PDIA4 FHOD1 SMARCC1 CDH2 ZMYM3	1.62e-05	1203	245	23	29180619
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	BRIX1 GTF3C4 DDX3X DDX6 MYBBP1A LARP1 SIRT6 PCF11 SETD2 SMARCC1 LAS1L CDH1 KDM1A	1.68e-05	440	245	13	34244565
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	MYC TNIK DIS3L IRAK1 CNTROB ERBIN DDX3X DDX6 PASK FANCG KATNIP CAMSAP2 ATG16L2 ZC3H12A PNISR SETD2 SUGP1 PRMT3 SNAPC2 LAS1L PRKX	1.68e-05	1038	245	21	26673895
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MYO1D DIS3L SPART DDX6 FAM120A PRRC2B DNAJC13 TAF1C LARP1 PRPF8 GSN NOSIP MICALL1 PDIA4 SMARCC1 LAS1L PALLD	1.74e-05	724	245	17	36232890
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	GTF3C4 DDX3X BPTF UBA2 XPNPEP1 PRPF8 CHAMP1 LAS1L PALLD ZMYM3 CDK2	2.67e-05	332	245	11	32786267
Pubmed	Sox9 plays multiple roles in the lung epithelium during branching morphogenesis.	MYC PTCH1 LAMA4 MSX1 CDH1	2.72e-05	50	245	5	24191021
Pubmed	PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.	PIK3CG CDH1 CDH2	2.81e-05	9	245	3	15192701
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	BRIX1 MYO1D GTF3C4 DDX3X DDX6 PASK FAM120A HMCN2 MRPL24 MYBBP1A CANX ERVK13-1 MAGOHB LARP1 C1orf167 PRPF8 CBS NOSIP WDR87 TMOD1 DDX3Y EIF3B KDM1A CDK2	2.84e-05	1335	245	24	29229926
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK GON4L ERBIN JMJD6 STARD9 KATNIP CAMSAP2 PRRC2B NRCAM MED13L YY1AP1 ZMYM3	3.62e-05	407	245	12	12693553
Pubmed	Drebrin, an actin-binding protein, is required for lens morphogenesis and growth.	NRCAM CDH1 CDH2	4.00e-05	10	245	3	33896079
Pubmed	Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning.	PTCH1 FMN1 MSX1	4.00e-05	10	245	3	12808456
Pubmed	The X-linked splicing regulator MBNL3 has been co-opted to restrict placental growth in eutherians.	MYC ESRP2 RBM20	4.00e-05	10	245	3	35476669
Pubmed	CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma.	MYC PTCH1 DDX3X	4.00e-05	10	245	3	26290144
Pubmed	Visceral endoderm and the primitive streak interact to build the fetal-placental interface of the mouse gastrula.	PTCH1 CDH1 CDH2	4.00e-05	10	245	3	28882402
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	IRAK1 ERBIN GTF3C4 BPTF PRRC2B MYBBP1A AHCTF1 ATG2B LARP1 CHAMP1 SETD2 SMARCC1 PALLD KDM1A	4.02e-05	549	245	14	38280479
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TNIK BRIX1 TRPM2 GTF3C4 DDX6 BLVRB FAM120A STARD9 RAMAC TMEM97 PRRC2B MYBBP1A AHCTF1 TAF1C MAGOHB LARP1 APOA1 PRPF8 NOSIP PCF11 SMARCC1 TMOD1 DDX3Y LAS1L	4.32e-05	1371	245	24	36244648
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	TNIK GTF3C4 DDX3X DDX6 MRPL24 MYBBP1A UBA2 PRPF8 CHAMP1 CBS NOSIP IARS2 SMARCC1 DDX3Y PRMT3 KDM1A	4.53e-05	704	245	16	29955894
Pubmed	Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis.	MYC LARP1	4.94e-05	2	245	2	35195778
Pubmed	MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo.	MYC PTCH1	4.94e-05	2	245	2	11922389
Pubmed	Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation.	OBSCN CDH2	4.94e-05	2	245	2	38127465
Pubmed	Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin.	CDH1 CDH2	4.94e-05	2	245	2	11171330
Pubmed	The Immunohistochemical Pattern of Epithelial-Mesenchymal Transition Markers In Endometrial Carcinoma.	CDH1 CDH2	4.94e-05	2	245	2	30829665
Pubmed	Molecular cloning and sequencing of calnexin-t. An abundant male germ cell-specific calcium-binding protein of the endoplasmic reticulum.	CLGN CANX	4.94e-05	2	245	2	8188695
Pubmed	MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma.	MYC MYCL	4.94e-05	2	245	2	34257619
Pubmed	Cadherin-mediated cell sorting not determined by binding or adhesion specificity.	CDH1 CDH2	4.94e-05	2	245	2	11790800
Pubmed	Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.	VCAN CDH1	4.94e-05	2	245	2	23002209
Pubmed	Prognostic significance of E-cadherin and N-cadherin expression in Gliomas.	CDH1 CDH2	4.94e-05	2	245	2	28851312
Pubmed	Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.	CDH1 CDH2	4.94e-05	2	245	2	14675278
Pubmed	Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders.	EPOR JAK2	4.94e-05	2	245	2	18006699
Pubmed	DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.	PTCH1 RET	4.94e-05	2	245	2	28069693
Pubmed	Versican V2 assembles the extracellular matrix surrounding the nodes of ranvier in the CNS.	UGT8 VCAN	4.94e-05	2	245	2	19535585
Pubmed	Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.	CDH1 CDH2	4.94e-05	2	245	2	28628116
Pubmed	The transcriptional regulator GON4L is required for viability and hematopoiesis in mice.	GON4L YY1AP1	4.94e-05	2	245	2	33864850
Pubmed	E-cadherin and N-cadherin Immunohistochemical Expression in Proliferating Urothelial Lesions: Potential Novel Cancer Predictive EMT Profiles.	CDH1 CDH2	4.94e-05	2	245	2	33979097
Pubmed	E- and N-cadherin distribution in developing and functional human teeth under normal and pathological conditions.	CDH1 CDH2	4.94e-05	2	245	2	12057916
Pubmed	Cadherin switch in tumor progression.	CDH1 CDH2	4.94e-05	2	245	2	15153430
Pubmed	Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule.	CHL1 NRCAM	4.94e-05	2	245	2	18588951
Pubmed	Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.	CDH1 CDH2	4.94e-05	2	245	2	36010583
Pubmed	JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.	EPOR JAK2	4.94e-05	2	245	2	8343951
Pubmed	c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level.	MYC CDH1	4.94e-05	2	245	2	23364919
Pubmed	Differential actions of the endocytic collagen receptor uPARAP/Endo180 and the collagenase MMP-2 in bone homeostasis.	MRC2 MMP2	4.94e-05	2	245	2	23940733
Pubmed	E-cadherin can replace N-cadherin during secretory-stage enamel development.	CDH1 CDH2	4.94e-05	2	245	2	25014356
Pubmed	E-cadherin to N-cadherin switching in the TGF-β1 mediated retinal pigment epithelial to mesenchymal transition.	CDH1 CDH2	4.94e-05	2	245	2	35500674
Pubmed	Comparative study on the mutation spectrum of L-MYC and C-MYC genes of blood cfDNA in patients with ovarian cancer and healthy females.	MYC MYCL	4.94e-05	2	245	2	37827180
Pubmed	Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin.	MMP2 CDH2	4.94e-05	2	245	2	19580633
Pubmed	Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function.	EPOR JAK2	4.94e-05	2	245	2	16982687
Pubmed	The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis.	GON4L YY1AP1	4.94e-05	2	245	2	20530203
Pubmed	Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.	DUOX2 APOA1	4.94e-05	2	245	2	25003194
Pubmed	Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.	MYC DDX6	4.94e-05	2	245	2	29314290
Pubmed	IRAK1-dependent Regnase-1-14-3-3 complex formation controls Regnase-1-mediated mRNA decay.	IRAK1 ZC3H12A	4.94e-05	2	245	2	34636324
Pubmed	Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively.	OAS2 GSN	4.94e-05	2	245	2	30148861
Pubmed	L-myc gene polymorphism and risk of thyroid cancer.	MYC MYCL	4.94e-05	2	245	2	18566574
Pubmed	Differential biological activity of disease-associated JAK2 mutants.	EPOR JAK2	4.94e-05	2	245	2	21362419
Pubmed	Modulation of E-Cadherin and N-Cadherin by ovarian steroids and embryonic stimuli.	CDH1 CDH2	4.94e-05	2	245	2	34710830
Pubmed	Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2.	EPOR JAK2	4.94e-05	2	245	2	17024180
Pubmed	The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours.	CDH1 CDH2	4.94e-05	2	245	2	30051197
Pubmed	Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation.	DDX3X DDX3Y	4.94e-05	2	245	2	35588748
Pubmed	Erythroid lineage-restricted expression of Jak2V617F is sufficient to induce a myeloproliferative disease in mice.	EPOR JAK2	4.94e-05	2	245	2	22371173
Pubmed	Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study.	CDH1 CDH2	4.94e-05	2	245	2	22072429
Pubmed	Expression of cadherin-8 mRNA in the developing mouse central nervous system.	CDH2 CDH8	4.94e-05	2	245	2	9336230
Pubmed	The immunohistochemical investigations of cadherin "switch" during epithelial-mesenchymal transition of tongue squamous cell carcinoma.	CDH1 CDH2	4.94e-05	2	245	2	25607384
Pubmed	E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.	MYC CDH1	4.94e-05	2	245	2	17146437
Pubmed	Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.	EPOR JAK2	4.94e-05	2	245	2	27998978
Pubmed	Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis.	DDX3X DDX3Y	4.94e-05	2	245	2	34437837
Pubmed	Characterization of D1Pas1, a mouse autosomal homologue of the human AZFa region DBY, as a nuclear protein in spermatogenic cells.	DDX3X DDX3Y	4.94e-05	2	245	2	11591417
Pubmed	Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.	JAK2 GAB1	4.94e-05	2	245	2	19665053
Pubmed	Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas.	CDH1 CDH2	4.94e-05	2	245	2	16377805
Interaction	LRRC7 interactions	TNIK ADGRB1 ERBIN DDX3X CDKL5 SHANK3 CDH1 CDH2	4.40e-07	58	242	8	int:LRRC7
Cytoband	16q24	SPIRE2 TAF1C CYBA	9.66e-05	17	245	3	16q24
GeneFamily	Fibronectin type III domain containing	CHL1 EPOR OBSCN NFASC PTPRQ USH2A NRCAM IGDCC3 CSF3R ASTN1 IGSF9B LRRN4	2.18e-08	160	162	12	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 OBSCN NFASC HMCN2 UNC5D NRCAM IGDCC3 HMCN1 IGSF9B PALLD	1.92e-06	161	162	10	593
GeneFamily	Adhesion G protein-coupled receptors, subfamily B	ADGRB1 ADGRB2	2.38e-04	3	162	2	912
GeneFamily	CD molecules\|Type I classical cadherins	CDH1 CDH2	7.84e-04	5	162	2	1185
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	BNIP2 ATCAY	1.63e-03	7	162	2	1299
GeneFamily	Fibulins	HMCN2 HMCN1	2.16e-03	8	162	2	556
Coexpression	P53_DN.V1_DN	CHL1 HGD SPART NRCAM SLC26A2 PPM1D CAPN3 VCAN DDX3Y CDH1	1.45e-05	194	243	10	M2697
Coexpression	DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE	MYC EPOR LPCAT1 MRPL51 JAK2 ASPM MYBBP1A SLC26A2 LARP1 MED13L ABHD4 IARS2 TMOD1 PRMT3 CABIN1 ATG4D	1.82e-05	497	243	16	MM3640
Coexpression	GSE27786_BCELL_VS_NKCELL_UP	CNTROB CEP68 CIITA JMJD6 ATG16L2 SZT2 P3H3 PDIA4 SETD2 IMMP2L	1.88e-05	200	243	10	M4805
Coexpression	GSE2585_THYMIC_DC_VS_MTEC_DN	SPART DDX6 RETREG3 CNGB1 SZT2 LARP1 OAS2 NBEA PPP1R3A SLC8A1	1.88e-05	200	243	10	M6283
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	ADGRB1 ADGRB2 NFASC CNTROB PASK ASPM MBD4 SLC4A8 NRCAM ATCAY UBA2 NBEA SLC8A1 AP3B2 SMARCC1 CDH2 CDCA5 KDM1A CDK2	2.17e-05	680	243	19	MM456
ToppCell	PND07-28-samps-Mesenchymal\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PTCH1 MRC2 MMP2 TCF21 SEPTIN4 GPX8 GSN HMCN1 VCAN PDE5A PALLD	1.14e-08	194	245	11	68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMP2 TCF21 NRCAM SEPTIN4 P3H3 LAMA4 GSN HMCN1 VCAN PDE5A PALLD	1.27e-08	196	245	11	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	HGD EPOR HPSE BLVRB PTPRQ TREML1 DCLRE1B GSN PRMT3 IMMP2L RASGRP2	1.57e-08	200	245	11	e4be88bcef2738915f711b32c95e9c613e7edf96
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	LILRB2 TRPM2 OBSCN ZNF774 FMN1 SH3BGR RBM20 SLC8A1 CDH2 PALLD	3.78e-08	170	245	10	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	PND07-Mesenchymal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMP2 TCF21 NRCAM SEPTIN4 GPX8 LAMA4 GSN VCAN PDE5A PALLD	1.44e-07	196	245	10	0050c7134473fbfd7b9f0ae8d6d337713e60b57d
ToppCell	PND03-Mesenchymal\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMP2 TCF21 NRCAM SEPTIN4 P3H3 LAMA4 GSN VCAN PDE5A PALLD	1.51e-07	197	245	10	e3053ef8f604b6892c21c03e12612b49d3d30f23
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFASC HMCN2 LAMA4 RBM20 SLC8A1 TMOD1 IGSF9B ASB2 CDH2 PALLD	1.51e-07	197	245	10	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LILRB2 FAM120A FMN1 PDIA2 PNLIPRP2 GSN SLC8A1 CSF3R PLEKHO2 VCAN	1.51e-07	197	245	10	9838dbd1623babf8de7e9126a28fe5d3666bce42
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFASC STARD9 TACR2 NRCAM LAMA4 SLC8A1 TMOD1 PDE5A IGSF9B ASB2	1.58e-07	198	245	10	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFASC STARD9 TACR2 NRCAM LAMA4 SLC8A1 TMOD1 PDE5A IGSF9B ASB2	1.58e-07	198	245	10	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB ASPM TREML1 PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.66e-07	199	245	10	2b754670fe77c2301afcdcfc73a1e52cc0cd1de3
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB ASPM TREML1 PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.66e-07	199	245	10	f894c88ecc7fd0edca28587801fa59352d10f750
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast\|Leuk-UTI / Disease, condition lineage and cell class	SRXN1 NPIPB15 MYO1D PKN3 SEPTIN4 PPM1D C1orf167 ASB2 CDCA5 ZMYM3	1.66e-07	199	245	10	1b17e6d5e6b994dec65efae2667f4f1f438161b1
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRB2 MEFV JAK2 CIITA TTYH3 MED13L SLC8A1 CSF3R VCAN WDFY3	1.73e-07	200	245	10	934c2efc780318c66d667ca75be0de350361d351
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	HGD EPOR HPSE TREML1 DCLRE1B GSN HEATR9 PDE5A PRMT3 RASGRP2	1.73e-07	200	245	10	326cae37cacd94b423a6ac8873ea56c5abaf0a0b
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OBSCN FMN1 SH3BGR RBM20 PPP1R3A SLC8A1 ASB2 CDH2 PALLD	4.47e-07	170	245	9	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMC3 GPR179 CNGB1 SLC4A8 ATCAY RET AP3B2 TMOD1 CDH2	5.99e-07	176	245	9	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMC3 GPR179 CNGB1 SLC4A8 ATCAY RET AP3B2 TMOD1 CDH2	5.99e-07	176	245	9	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OBSCN SH3BGR RBM20 PPP1R3A SLC8A1 TMOD1 ASB2 CDH2 PALLD	8.68e-07	184	245	9	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	facs-Skin-Anagen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 IL20RA ESRP2 UBA2 IL17RC XPNPEP1 PDIA4 DDX3Y EIF3B	9.50e-07	186	245	9	9a7932d0a208f3997216bd21a72913cc82b59fc9
ToppCell	COPD-Myeloid-Mast\|COPD / Disease state, Lineage and Cell class	TNIK RIC1 NRCAM SLC26A2 DUOX2 ADAMTS7 TMOD1 PRKX PALLD	9.50e-07	186	245	9	def6f0f284acc2154738574c8c5d3d2a5ef1f208
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FAM186A USH2A UNC5D TTYH3 MED13L SLC8A1 CSF3R VCAN ASTN1	9.50e-07	186	245	9	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MMP2 TCF21 NRCAM SEPTIN4 LAMA4 FHOD1 VCAN PDE5A PALLD	1.04e-06	188	245	9	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PTCH1 MRC2 MMP2 TCF21 SEPTIN4 GSN HMCN1 VCAN PALLD	1.09e-06	189	245	9	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHRR CFAP119 SH3RF1 SEPTIN4 GPX8 LAMA4 ESAM SHANK3 GAB1	1.09e-06	189	245	9	ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMP2 TCF21 SH3BGR RBM20 GSN SLC8A1 VCAN ASB2 CDH2	1.13e-06	190	245	9	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN PAQR9 SH3BGR RBM20 PPP1R3A SLC8A1 TMOD1 ASB2 CDH2	1.18e-06	191	245	9	97fb4232417a39801e87725755fd16a57c250209
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN PAQR9 SH3BGR RBM20 PPP1R3A SLC8A1 TMOD1 ASB2 CDH2	1.18e-06	191	245	9	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMC3 CNGB1 SLC4A8 ATCAY NBEA RET ARVCF TMOD1 CDH2	1.24e-06	192	245	9	fe9297cb65234d9f511bab1a5dbf2679d5a4cd15
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.24e-06	192	245	9	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 SH3BGR SLC8A1 ARVCF ASTN1 PDE5A ASB2 PALLD RASGRP2	1.24e-06	192	245	9	eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FMO6P UMODL1 PTPRQ USH2A ESPNL DUOX2 GUCY2C HEATR9 CYP4F22	1.29e-06	193	245	9	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC DCSTAMP HMCN2 MRC2 MMP2 TCF21 LAMA4 VCAN PALLD	1.29e-06	193	245	9	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMC3 CNGB1 SLC4A8 ATCAY NBEA RET ARVCF TMOD1 CDH2	1.29e-06	193	245	9	a189d46c39067b717509cd144e0225cc93d7731d
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.29e-06	193	245	9	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC DCSTAMP HMCN2 MRC2 MMP2 TCF21 LAMA4 VCAN PALLD	1.29e-06	193	245	9	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.29e-06	193	245	9	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 SH3BGR UBA2 ARVCF ASTN1 PDE5A ASB2 PALLD RASGRP2	1.29e-06	193	245	9	0266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.41e-06	195	245	9	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD RASGRP2	1.41e-06	195	245	9	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.41e-06	195	245	9	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.41e-06	195	245	9	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 GSN FHOD1 VCAN PALLD	1.41e-06	195	245	9	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC JAK2 HMCN2 LAMA4 SLC8A1 TMOD1 PDE5A ASB2 PALLD	1.47e-06	196	245	9	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 LAMA4 GSN FHOD1 PALLD	1.47e-06	196	245	9	db64ab27374f82553ee577aec056141170f3656f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC JAK2 HMCN2 LAMA4 SLC8A1 TMOD1 PDE5A ASB2 PALLD	1.47e-06	196	245	9	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFASC TACR2 NRCAM LAMA4 SLC8A1 TMOD1 IGSF9B ASB2 PALLD	1.47e-06	196	245	9	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC2 MMP2 TCF21 NRCAM SEPTIN4 LAMA4 GSN FHOD1 PALLD	1.47e-06	196	245	9	617103f4a09e009fe96c28eb5e40505a4fd6dcf4
ToppCell	MatrixFB\|World / shred on cell class and cell subclass (v4)	MMP2 TCF21 SEPTIN4 P3H3 LAMA4 GSN VCAN PDE5A PALLD	1.53e-06	197	245	9	e325de44e32021a36fffb7b7e88167b46bb051c7
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LILRB2 TRPM2 IRAK1 HPSE FMN1 TTYH3 SLC8A1 CSF3R VCAN	1.53e-06	197	245	9	a6aa5991d566c28440f7e24a30933e69669064f2
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega\|Control_saline / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB TREML1 PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.60e-06	198	245	9	1a39a98beef68e1e6d3adc25270a3336fcc5baf4
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMC3 SHD CNGB1 SLC4A8 ATCAY NBEA RET TMOD1 CDH2	1.60e-06	198	245	9	b58138581f1a9073267d64c1211c5b9b4de71d3e
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary\|Control_saline / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB TREML1 PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.60e-06	198	245	9	cfc2a860bae883299987d3e374d0476ca20e1bdd
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFASC SHD CNGB1 SLC4A8 ATCAY NBEA RET TMOD1 CDH2	1.60e-06	198	245	9	dac7b68bb8f1c4d8aa7fdfada61f79956866e874
ToppCell	E18.5-Mesenchymal\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMP2 TCF21 SEPTIN4 P3H3 LAMA4 GSN VCAN PDE5A PALLD	1.60e-06	198	245	9	a16aa41eab2e297e56de43c22c355df0f79315da
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB ASPM PAQR9 DNAI2 TMOD1 CYP4F22 CDCA5	1.66e-06	199	245	9	565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 TMC3 CNGB1 SLC4A8 ATCAY NBEA RET TMOD1 CDH2	1.66e-06	199	245	9	b4824d3683a4e3025b8e74a0f1755b331b2a0ba7
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB ASPM TREML1 PAQR9 DNAI2 TMOD1 CYP4F22	1.66e-06	199	245	9	6c174dbcc25b980f10a3d1dfe39e613acac73bb6
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB ASPM TREML1 PAQR9 DNAI2 TMOD1 CYP4F22	1.66e-06	199	245	9	284ee9632413f6404fc0b0c7c393ad813db834f2
ToppCell	E16.5-Mesenchymal\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMP2 TCF21 SEPTIN4 P3H3 LAMA4 VCAN PDE5A PALLD RASGRP2	1.66e-06	199	245	9	ebd9ca151434f5ca27a82d4f1815a1ea500c1989
ToppCell	normal_Lung-Fibroblasts\|normal_Lung / Location, Cell class and cell subclass	MYC MRC2 MMP2 TCF21 P3H3 GPX8 LAMA4 GSN PALLD	1.73e-06	200	245	9	803cf7f1382d07220249029cd220233232027689
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFASC ERBIN UGT8 CANX GSN ABHD4 DDX3Y EIF3B GAB1	1.73e-06	200	245	9	f0c338877e39226a90c4effe12f6501d33542a73
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPOR BLVRB ASPM TREML1 PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.73e-06	200	245	9	f99e214eb680fd82a33f2b1524fbfca265d1cc42
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPOR BLVRB ASPM TREML1 PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.73e-06	200	245	9	d85074b362b11e5a523a5325d203a61aa2759a7a
ToppCell	367C-Fibroblasts\|367C / Donor, Lineage, Cell class and subclass (all cells)	MRC2 MMP2 TCF21 P3H3 GPX8 LAMA4 HMCN1 PDE5A PALLD	1.73e-06	200	245	9	c5aaa20c59b9f11b8abdf5de9e3fc54f4e6e39f7
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPOR SRXN1 BLVRB ASPM PAQR9 DCLRE1B DNAI2 TMOD1 CYP4F22	1.73e-06	200	245	9	f100edfd2b3b742458cbbf34de9c403c4d272d3c
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFASC HMCN2 LAMA4 RBM20 SLC8A1 TMOD1 IGSF9B ASB2 PALLD	1.73e-06	200	245	9	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	MYCL CCDC168 PTCH1 DDX6 SZT2 VCAN LRRN4 KDM1A	1.77e-06	149	245	8	768877bade04ca0321593b8470b5011ad8270431
ToppCell	RV-03._Atrial_Cardiomyocyte\|RV / Chamber and Cluster_Paper	NPIPB7 OBSCN PDIA2 CBS RBM20 SLC8A1 PALLD	1.88e-06	105	245	7	49e16b11f16e83a7d17d162c14bce991201bcc2a
ToppCell	Leuk-UTI-Lymphocyte-B-Plasmablast\|Leuk-UTI / Disease, Lineage and Cell Type	SRXN1 MYO1D NPIPB9 NPIPB8 PKN3 SEPTIN4 C1orf167 CDCA5	2.75e-06	158	245	8	05a29c2d5506a25ccdfa4c6a86e9188977a18272
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 SPART NFASC PTCH1 MRC2 LAMA4 RET FHOD1	3.31e-06	162	245	8	bfaeff19bb56598fdc8c82be71d51787cf13928f
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK ARHGEF6 NRCAM SLC26A2 ZNF618 NBEA ADAMTS7 PRKX	3.79e-06	165	245	8	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK ARHGEF6 NRCAM SLC26A2 ZNF618 NBEA ADAMTS7 PRKX	3.79e-06	165	245	8	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK ARHGEF6 NRCAM SLC26A2 ZNF618 NBEA ADAMTS7 PRKX	3.79e-06	165	245	8	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 TRPM2 MEFV CIITA FMN1 TREML1 TTYH3 SLC8A1	4.33e-06	168	245	8	61a5435b27b01ff1a509ea463a6af220c5d2c9b3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 TRPM2 MEFV CIITA FMN1 TREML1 TTYH3 SLC8A1	4.33e-06	168	245	8	26fce414439ccd204e3acb41f2b4f75072df5a26
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPAG1 STARD9 MMP2 SH3RF1 TCF21 SEPTIN4 FANCL PALLD	4.53e-06	169	245	8	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	TNIK ARHGEF6 NRCAM SLC26A2 NBEA ADAMTS7 TMOD1 PRKX	4.53e-06	169	245	8	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM2 PTCH1 MEFV FANCG PIK3CG KATNIP OAS2 CSF3R	4.73e-06	170	245	8	f3d5678669dcaed1836014cea543758b7ccc6b46
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	TNIK ARHGEF6 NRCAM SLC26A2 NBEA ADAMTS7 TMOD1 PRKX	4.73e-06	170	245	8	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYC NFASC CYP4X1 MMP2 LAMA4 VCAN TMOD1 PALLD	4.94e-06	171	245	8	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3BGR CAPN3 UBA2 ARVCF PITPNM3 ASTN1 ASB2 PALLD	5.61e-06	174	245	8	197686570cec6d96a92e77e6409325d3bfe6f991
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3BGR CAPN3 UBA2 ARVCF PITPNM3 ASTN1 ASB2 PALLD	5.61e-06	174	245	8	2eee7b5471672b439f95eba11494c2adf8cb7006
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC ESPNL DGKD RBM20 SLC8A1 ASTN1 IGSF9B ASB2	5.85e-06	175	245	8	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC ESPNL DGKD RBM20 SLC8A1 ASTN1 IGSF9B ASB2	5.85e-06	175	245	8	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OBSCN NFASC HMCN2 MRC2 TCF21 GPX8 NBEA VCAN	6.36e-06	177	245	8	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADGRB2 TACR2 NRCAM LAMA4 TMOD1 PDE5A IGSF9B PALLD	6.63e-06	178	245	8	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADGRB2 TACR2 NRCAM LAMA4 TMOD1 PDE5A IGSF9B PALLD	6.63e-06	178	245	8	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	wk_15-18-Epithelial-PNS-KCNIP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHL1 NFASC TMC3 SHD CNGB1 ATCAY RET ASTN1	6.91e-06	179	245	8	e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTCH1 GPR179 UNC5D ARHGEF6 TCF21 RAD51AP2 PDE5A CDH2	6.91e-06	179	245	8	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTCH1 GPR179 UNC5D ARHGEF6 TCF21 RAD51AP2 PDE5A CDH2	6.91e-06	179	245	8	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OBSCN SH3BGR RBM20 PPP1R3A SLC8A1 TMOD1 CDH2 PALLD	7.50e-06	181	245	8	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK OBSCN SH3BGR DGKD RBM20 SLC8A1 CDH2 PALLD	7.80e-06	182	245	8	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYCL CNGB1 SLC4A8 NBEA RET ARVCF TMOD1 CDH2	7.80e-06	182	245	8	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	COPD-Myeloid-Mast\|World / Disease state, Lineage and Cell class	TNIK RIC1 NRCAM SLC26A2 DUOX2 ADAMTS7 TMOD1 PRKX	7.80e-06	182	245	8	68a1e7b804f309bfd6c23d65fad20a9a962712ae
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPOR GPR179 ARHGEF6 SLC4A8 SEPTIN4 PDE5A CDH2 RASGRP2	8.79e-06	185	245	8	b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e
ToppCell	wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHL1 PAPOLB NFASC CNGB1 ATCAY RET MSX1 AP3B2	9.15e-06	186	245	8	72f7427d62d65e37bb0bf99229a1b75df081a128
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PTCH1 FMN1 SLC4A8 NRCAM DGKD VCAN WDFY3 CABIN1	9.51e-06	187	245	8	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NYNRIN NRCAM PREPL HMCN1 SPIDR PALLD KDM1A GAB1	9.89e-06	188	245	8	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NYNRIN NRCAM PREPL HMCN1 SPIDR PALLD KDM1A GAB1	9.89e-06	188	245	8	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A	MYCL DDX3X PRRC2B ZC3H12A CAPN3 LARP1 MED13L MICALL1 CSF3R ARVCF SUGP1 CFAP74	1.34e-06	196	242	12	1440_UP
Drug	LY2784544	MYC JAK2 MMP2	4.71e-06	4	242	3	ctd:C581039
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; HL60; HT_HG-U133A	LILRB2 PLK3 PNOC SZT2 CAPN3 POMGNT1 MICALL1 SUGP1 TMOD1 SPIDR RASGRP2	7.40e-06	193	242	11	2129_DN
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; PC3; HT_HG-U133A	MYCL EPOR MYO1D GON4L DDX3X CEP68 JMJD6 UGT8 LAMA4 SUGP1 SPIDR	7.77e-06	194	242	11	5776_DN
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; HL60; HT_HG-U133A	MYCL TNIK CLGN PLCB3 ZC3H12A NRCAM TAF1C CAPN3 PDIA4 SUGP1 WDFY3	8.99e-06	197	242	11	2979_DN
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MYCL EPOR DDX3X PASK KATNIP PRRC2B SZT2 SLC26A2 MICALL1 SPIDR CABIN1	9.43e-06	198	242	11	7334_DN
Disease	Intellectual Disability	CHL1 GON4L DDX3X DDX6 BPTF ALKBH8 NBEA MED13L CHAMP1 PREPL SHANK3 SETD2 SLC4A10 ASTN1 LAS1L CDH2	7.41e-07	447	236	16	C3714756
Disease	primary biliary cholangitis (implicated_via_orthology)	JAK2 ZC3H12A PDE5A	2.01e-06	4	236	3	DOID:12236 (implicated_via_orthology)
Disease	Global developmental delay	INTS1 SPART DDX6 ALKBH8 SZT2 NBEA CDH2 KDM1A	1.23e-05	133	236	8	C0557874
Disease	MASA syndrome (implicated_via_orthology)	CHL1 NFASC NRCAM	1.73e-05	7	236	3	DOID:0060246 (implicated_via_orthology)
Disease	childhood medulloblastoma (implicated_via_orthology)	DDX3X DDX3Y	6.37e-05	2	236	2	DOID:3869 (implicated_via_orthology)
Disease	salivary gland cancer (implicated_via_orthology)	GON4L YY1AP1	6.37e-05	2	236	2	DOID:8850 (implicated_via_orthology)
Disease	Diffuse Large B-Cell Lymphoma	MYC JAK2 PIK3CG IMMP2L CDK2	7.88e-05	55	236	5	C0079744
Disease	Neurodevelopmental Disorders	DDX3X CDKL5 PPM1D MED13L SETD2 WDFY3	1.05e-04	93	236	6	C1535926
Disease	stomach cancer (is_marker_for)	PDCD1 ADGRB1 PTCH1 JAK2 ASPM NBEA SETD2	1.52e-04	142	236	7	DOID:10534 (is_marker_for)
Disease	pancreatic cancer (is_marker_for)	PTCH1 MMP2 ABCC5 APOA1 RET PALLD	1.65e-04	101	236	6	DOID:1793 (is_marker_for)
Disease	hepatocellular carcinoma (is_marker_for)	MYC PDCD1 PTCH1 DDX3X JAK2 ASPM APOA1 SMARCC1 CDH1 KDM1A	1.69e-04	301	236	10	DOID:684 (is_marker_for)
Disease	familial erythrocytosis 1 (is_implicated_in)	EPOR JAK2	1.90e-04	3	236	2	DOID:0060652 (is_implicated_in)
Disease	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR JAK2	1.90e-04	3	236	2	133100
Disease	atrial fibrillation (implicated_via_orthology)	RBM20 SLC8A1	1.90e-04	3	236	2	DOID:0060224 (implicated_via_orthology)
Disease	Primary familial polycythemia due to EPO receptor mutation	EPOR JAK2	1.90e-04	3	236	2	cv:C4551637
Disease	African Burkitt's lymphoma	MYC SALL3 RET	2.14e-04	15	236	3	C0343640
Disease	Burkitt Leukemia	MYC SALL3 RET	2.14e-04	15	236	3	C4721444
Disease	Developmental delay (disorder)	SPART ALKBH8 SZT2 KDM1A	2.14e-04	37	236	4	C0424605
Disease	Cleft upper lip	MYC PTCH1 ESRP2 MSX1	2.63e-04	39	236	4	C0008924
Disease	Autistic Disorder	MYO1D PASK PIK3CG MBD4 NRCAM TAF1C NBEA SHANK3 IMMP2L	2.71e-04	261	236	9	C0004352
Disease	retinitis pigmentosa (is_implicated_in)	USH2A CNGB1 POMGNT1 PRPF8	3.20e-04	41	236	4	DOID:10584 (is_implicated_in)
Disease	Myxedema, Congenital	DUOX2 IGSF1	3.78e-04	4	236	2	C1578691
Disease	Sertoli cell-only syndrome (implicated_via_orthology)	DDX3X DDX3Y	3.78e-04	4	236	2	DOID:0050457 (implicated_via_orthology)
Disease	Endemic Cretinism	DUOX2 IGSF1	3.78e-04	4	236	2	C0342200
Disease	Childhood Medulloblastoma	MYC MYCL PTCH1 PIK3CG	3.85e-04	43	236	4	C0278510
Disease	Melanotic medulloblastoma	MYC MYCL PTCH1 PIK3CG	3.85e-04	43	236	4	C1275668
Disease	Medullomyoblastoma	MYC MYCL PTCH1 PIK3CG	3.85e-04	43	236	4	C0205833
Disease	Desmoplastic Medulloblastoma	MYC MYCL PTCH1 PIK3CG	3.85e-04	43	236	4	C0751291
Disease	Adult Medulloblastoma	MYC MYCL PTCH1 PIK3CG	3.85e-04	43	236	4	C0278876
Disease	Cleft Palate	MYC INTS1 PTCH1 MED13L MSX1	4.90e-04	81	236	5	C0008925
Disease	Amyloidosis, familial visceral	APOA1 GSN	6.27e-04	5	236	2	C0268389
Disease	Adult Diffuse Large B-Cell Lymphoma	JAK2 CDK2	6.27e-04	5	236	2	C1332201
Disease	lung adenocarcinoma (is_implicated_in)	MYC PTCH1 JAK2 SETD2	6.37e-04	49	236	4	DOID:3910 (is_implicated_in)
Disease	Medulloblastoma	MYC MYCL PTCH1 PIK3CG	6.88e-04	50	236	4	C0025149
Disease	Neoplasm Invasiveness	EPOR HPSE ALKBH8 MMP2 CDH1 CDH2 KDM1A	7.30e-04	184	236	7	C0027626
Disease	melanoma	EPOR PDCD1 HPSE JMJD6 RET CBS KDM1A CDK2	9.12e-04	248	236	8	C0025202
Disease	pulmonary hypertension (implicated_via_orthology)	MYC TACR2 PDE5A CYBA	9.22e-04	54	236	4	DOID:6432 (implicated_via_orthology)
Disease	Chanarin-Dorfman syndrome (implicated_via_orthology)	PNPLA5 ABHD4	9.35e-04	6	236	2	DOID:0050729 (implicated_via_orthology)
Disease	Familial erythrocytosis	EPOR JAK2	9.35e-04	6	236	2	cv:C0152264
Disease	Amyloidosis, hereditary systemic	APOA1 GSN	9.35e-04	6	236	2	cv:C4081731
Disease	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET ARVCF	9.35e-04	6	236	2	C3888239
Disease	leukemia	JAK2 FANCG SETD2 CSF3R	9.88e-04	55	236	4	C0023418
Disease	Malignant neoplasm of breast	EPOR OBSCN HPSE DDX3X ALKBH8 JMJD6 MMP2 TREML1 NRCAM PPM1D MAGOHB GSN MICALL1 PPP1R3A SETD2 HEATR9 CDH1 CDH2 GAB1	1.10e-03	1074	236	19	C0006142
Disease	Adenoid Cystic Carcinoma	ERBIN ASPM SETD2 VCAN CDH1	1.27e-03	100	236	5	C0010606
Disease	Pancreatic Neoplasm	MYC PTCH1 MMP2 CDH1 PALLD	1.27e-03	100	236	5	C0030297
Disease	retinitis pigmentosa (implicated_via_orthology)	USH2A CNGB1 PRPF8	1.28e-03	27	236	3	DOID:10584 (implicated_via_orthology)
Disease	Malignant neoplasm of pancreas	MYC PTCH1 MMP2 CDH1 PALLD	1.39e-03	102	236	5	C0346647
Disease	brain ischemia (biomarker_via_orthology)	EPOR IRAK1 MMP2 RET SLC8A1	1.39e-03	102	236	5	DOID:2316 (biomarker_via_orthology)
Disease	systemic lupus erythematosus (is_implicated_in)	EPOR PDCD1 CIITA APOA1	1.55e-03	62	236	4	DOID:9074 (is_implicated_in)
Disease	Colorectal Carcinoma	CHL1 MYC SALL3 OBSCN CDKL5 FANCG MMP2 CAMSAP2 NRCAM ABCC5 RET GUCY2C LAS1L CDH1	1.67e-03	702	236	14	C0009402
Disease	Polycythemia	EPOR JAK2	1.73e-03	8	236	2	C0032461
Disease	obesity (implicated_via_orthology)	CAPN9 PLCB3 CAPN3 MED13L PNPLA5 ABHD4 GUCY2C	1.79e-03	215	236	7	DOID:9970 (implicated_via_orthology)
Disease	Coronary Arteriosclerosis	IRAK1 TCF21 APOA1 ADAMTS7	1.84e-03	65	236	4	C0010054
Disease	Coronary Artery Disease	IRAK1 TCF21 APOA1 ADAMTS7	1.84e-03	65	236	4	C1956346
Disease	myocardial infarction (biomarker_via_orthology)	EPOR PLCB3 MMP2 GSN VCAN CYBA	1.87e-03	160	236	6	DOID:5844 (biomarker_via_orthology)
Disease	Neoplasm Metastasis	MYC EPOR HPSE MMP2 PDE5A CDH1 CDH2	1.89e-03	217	236	7	C0027627
Disease	MYELODYSPLASTIC SYNDROME	MYC FANCG FANCL CSF3R	2.06e-03	67	236	4	C3463824
Disease	Erythrocytosis familial, 1	EPOR JAK2	2.21e-03	9	236	2	C4551637
Disease	Erythrocytosis	EPOR JAK2	2.21e-03	9	236	2	C1527405
Disease	Cleft palate with cleft lip	MSX1 CDH1	2.21e-03	9	236	2	C0158646
Disease	liver cancer (is_marker_for)	JAK2 SETD2	2.21e-03	9	236	2	DOID:3571 (is_marker_for)
Disease	Ovarian Cysts	MAGOHB IARS2 TMOD1	2.74e-03	35	236	3	C0029927
Disease	Corpus Luteum Cyst	MAGOHB IARS2 TMOD1	2.74e-03	35	236	3	C0010093
Disease	Leukemia, Myelocytic, Acute	MYC JAK2 FANCG FANCL SETD2 CSF3R	2.77e-03	173	236	6	C0023467
Disease	Burkitt Lymphoma	MYC SALL3 RET	2.97e-03	36	236	3	C0006413
Disease	Ductal Carcinoma	MYC CDH1	3.34e-03	11	236	2	C1176475
Disease	visual epilepsy (is_implicated_in)	CDKL5 ASPM	3.34e-03	11	236	2	DOID:11832 (is_implicated_in)
Disease	Marfan Syndrome	MMP2 CBS	3.34e-03	11	236	2	C0024796
Disease	renal cell carcinoma (is_marker_for)	MYC PDCD1 ADGRB1 MMP2 SMARCC1	3.74e-03	128	236	5	DOID:4450 (is_marker_for)
Disease	Drug-induced depressive state	OAS2 CBS	3.99e-03	12	236	2	C0338715
Disease	intracranial aneurysm (is_implicated_in)	MMP2 VCAN	3.99e-03	12	236	2	DOID:10941 (is_implicated_in)
Disease	Myeloproliferative disease	JAK2 ATG2B	3.99e-03	12	236	2	C0027022
Disease	Cardiomegaly	PIK3CG SIRT6 GSN CABIN1	4.29e-03	82	236	4	C0018800
Disease	Cardiac Hypertrophy	PIK3CG SIRT6 GSN CABIN1	4.29e-03	82	236	4	C1383860
Disease	Mesothelioma	JMJD6 GSN CDH1	4.30e-03	41	236	3	C0025500
Disease	white matter microstructure measurement	TNIK SPIRE2 PTCH1 BPTF FAM120A ABCC5 VCAN WDFY3 ASB2	4.38e-03	390	236	9	EFO_0005674
Disease	Cleft palate, isolated	MYC PTCH1 MSX1	4.61e-03	42	236	3	C1837218
Disease	acute myeloid leukemia (is_implicated_in)	MEFV JAK2 CSF3R CDH1	4.67e-03	84	236	4	DOID:9119 (is_implicated_in)
Disease	cholangiocarcinoma (biomarker_via_orthology)	EPOR MMP2	4.69e-03	13	236	2	DOID:4947 (biomarker_via_orthology)
Disease	hematologic cancer (implicated_via_orthology)	JAK2 UBA2	4.69e-03	13	236	2	DOID:2531 (implicated_via_orthology)
Disease	ovary epithelial cancer (is_marker_for)	ASPM PLK3	4.69e-03	13	236	2	DOID:2152 (is_marker_for)
Disease	breast cancer (biomarker_via_orthology)	MYC KDM1A	4.69e-03	13	236	2	DOID:1612 (biomarker_via_orthology)
Disease	juvenile rheumatoid arthritis (is_implicated_in)	CIITA SLC26A2	4.69e-03	13	236	2	DOID:676 (is_implicated_in)
Disease	Congenital Hypothyroidism	DUOX2 IGSF1	4.69e-03	13	236	2	C0010308
Disease	subiculum volume	TNIK VCAN SLC4A10	4.92e-03	43	236	3	EFO_0009399
Disease	glioblastoma (is_marker_for)	ADGRB1 ASPM MMP2	5.25e-03	44	236	3	DOID:3068 (is_marker_for)
Disease	Thyroid carcinoma	EPOR RET CDH1	5.25e-03	44	236	3	C0549473
Disease	Profound Mental Retardation	CHL1 GON4L MED13L SHANK3 SLC4A10	5.30e-03	139	236	5	C0020796
Disease	Mental Retardation, Psychosocial	CHL1 GON4L MED13L SHANK3 SLC4A10	5.30e-03	139	236	5	C0025363
Disease	Mental deficiency	CHL1 GON4L MED13L SHANK3 SLC4A10	5.30e-03	139	236	5	C0917816
Disease	Fanconi anemia	FANCG FANCL	5.44e-03	14	236	2	cv:C0015625
Disease	unipolar depression, mood disorder, response to antidepressant	SLC4A8 CDH8	5.44e-03	14	236	2	EFO_0003761, EFO_0004247, GO_0036276
Disease	thyroid gland papillary carcinoma (is_marker_for)	MYC CDH1	5.44e-03	14	236	2	DOID:3969 (is_marker_for)
Disease	Autosomal recessive limb-girdle muscular dystrophy	CAPN3 POMGNT1	5.44e-03	14	236	2	cv:C2931907
Disease	Malignant neoplasm of salivary gland	ASPM VCAN CDH1	5.60e-03	45	236	3	C0220636
Disease	diabetic retinopathy (biomarker_via_orthology)	PIK3CG KDM1A CYBA	5.60e-03	45	236	3	DOID:8947 (biomarker_via_orthology)
Disease	cleft lip (is_implicated_in)	MSX1 CDH1	6.24e-03	15	236	2	DOID:9296 (is_implicated_in)
Disease	hepatoblastoma (is_marker_for)	APOA1 CDH1	6.24e-03	15	236	2	DOID:687 (is_marker_for)
Disease	anemia (implicated_via_orthology)	SLC4A8 SLC4A10	6.24e-03	15	236	2	DOID:2355 (implicated_via_orthology)
Disease	Salivary Gland Neoplasms	ASPM VCAN CDH1	6.32e-03	47	236	3	C0036095

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPRKLNLEWEDCPPV	UMODL1	301	Q5DID0
APVVKREPLDSPQWA	AHRR	656	A9YTQ3
EEPEEEPKVKTQWPR	ADGRB2	281	O60241
EPKVKTQWPRSADEP	ADGRB2	286	O60241
DQKEPTPFIIEWIPD	C2orf42	511	Q9NWW7
EAPLRAWKPTAEQPE	ERICH3	806	Q5RHP9
PPGKSKVPRDWREQV	ERBIN	1186	Q96RT1
WEKPSPIQEESIPIA	DDX6	116	P26196
DFPDKTWPPELSRTL	ADGRF3	131	Q8IZF5
RPLTVEWTKDTPVPE	C1orf167	171	Q5SNV9
LPEIWPKTPSAAAVR	CDCA5	41	Q96FF9
ISEWVIPIRSCVKPP	ERVK13-1	196	Q9NX77
FWVPEDKDIPARVTL	EIF3B	481	P55884
APEPEPLEKEACEKW	ATG16L2	256	Q8NAA4
EPPQIIKPWSLSCLR	ARHGEF6	581	Q15052
KEPRWRDPELPEVLA	ARVCF	351	O00192
PWKEQTAEKPVPALS	VCAN	1036	P13611
REPSLKQWPSRVPQK	CEP68	371	Q76N32
PTWVKKELEPLQPSP	ADGRB1	1541	O14514
EKVQWKELRPQALPP	ALKBH8	121	Q96BT7
EVSNKLPKWPEPVEQ	CIITA	326	P33076
EDWAVIKEKAEPPRP	ASB2	581	Q96Q27
WDPTKVPPRLQAVTD	BLVRB	116	P30043
PSEIRAPPAWVKAVA	ABHD4	181	Q8TB40
AEEKPIEIQWVKPEP	BRIX1	311	Q8TDN6
EPPQSPWDRVKDLAT	APOA1	26	P02647
PPWVKVPEDLKDPEV	DPPA5	11	A6NC42
WPKDVNPLELEQTIR	DNAI2	81	Q9GZS0
WDLENPNKPELALKP	DNAI2	201	Q9GZS0
CVKPPLEEVPEDEWQ	BPTF	416	Q12830
EKLSPWPADLEKQPS	DCLRE1B	376	Q9H816
PEDWRKSEVSPRIPE	ASPM	426	Q8IZT6
WLPLSKSFVIPPAEL	ASTN1	551	O14525
DDFDWPRIVLKINPP	ATG2B	841	Q96BY7
LPPPWRDRTNEVFKD	ADAMTS7	1206	Q9UKP4
EEQLEPASWSRKTPP	AP3B2	781	Q13367
PLLVATFWPELPEKI	MMP2	506	P08253
LPLVPRLSEAEKVWE	RAD51AP2	51	Q09MP3
KRPPESPPIVEEWNS	RAMAC	31	Q9BTL3
VELKQPLSLPSWEPE	RBM20	1126	Q5T481
KDFLWPLPIIPASSI	RIC1	1116	Q4ADV7
RLQAVWPPPKTKDTE	FMN1	696	Q68DA7
NSILPPKKDLWTAPE	GUCY2C	636	P25092
WQKLESVLPPERLPV	IMMP2L	156	Q96T52
VLPKDILQERIPWVP	JAK2	706	O60674
PWTPAALIPEALREK	P3H3	406	Q8IVL6
LECVRFVPPPKDWKI	LRRC69	301	Q6ZNQ3
DKVLPSFWIPSLTPE	NOSIP	156	Q9Y314
EWPNPVLLKEPEERN	PAPOLB	281	Q9NRJ5
WSKPLPPSERLEQEL	DDX3X	136	O00571
VPTRDERGQPIPEWK	ESPNL	436	Q6ZVH7
RREEPEKWPLPPIVD	LARP1	476	Q6PKG0
RARPWFEEPPKAVEL	PASK	971	Q96RG2
EKEPEQPPALWRKVV	LPCAT1	81	Q8NF37
PTWPPEFKPLEILQK	JMJD6	246	Q6NYC1
PKPLITWEKNRVPID	IGDCC3	166	Q8IVU1
LFRPSWAIPPKIEQL	MED13L	971	Q71F56
IVEEPPRWTKKPQSA	CHL1	326	O00533
PPRPPVLEEWTSAAK	RASGRP2	401	Q7LDG7
DIWFPEEKPLPTAFL	INTS1	1191	Q8N201
PSRSPLWTKEKLEPI	NRCAM	141	Q92823
TAPEKPQKPTPEWEV	GPR179	1746	Q6PRD1
IKPLPEWEELQAPVR	GAB1	536	Q13480
TPQVEWTKDRQPVLP	HMCN2	1466	Q8NDA2
PPAKPWTSLLEEKEE	KATNIP	376	O60303
KEEWQDEDLPRPLPE	ATCAY	16	Q86WG3
KPPQVPRWSPIRAEE	FRMD7	501	Q6ZUT3
EWPGPKERSSPIIIQ	DUOX2	651	Q9NRD8
VRGEQWTPIEPKPRE	CYBA	126	P13498
KPLWIEEPTSPDDIL	ENOSF1	271	Q7L5Y1
LDFQWREKTPEPPVP	PDCD1	226	Q15116
PLNIPDVSKDKRFPW	PDE5A	421	O76074
IPKPKFLLSETWVPL	DCSTAMP	366	Q9H295
PKRWRVDEVEQSPKP	NPIPB8	381	E9PQR5
IPKPTLWAEPDSVIT	LILRB2	26	Q8N423
PPDRWANVKVECEPS	MRC2	371	Q9UBG0
EQLLKELPWPPTFEK	DPP3	351	Q9NY33
ELPWPPTFEKDKFLT	DPP3	356	Q9NY33
PKAIKAWNNPSPRVE	LAS1L	291	Q9Y4W2
RKDPPWITLVQAEPK	MICALL1	366	Q8N3F8
KPNIPWLFLTDPRLA	FMO6P	451	O60774
VPVPEKWTTPQEIKQ	MEFV	541	O15553
NRLPPEFSPVIIKEW	FAM120A	631	Q9NZB2
LKTWSPPAEELDAPL	FANCG	181	O15287
IPPDWDQRPVKTLVG	PDIA2	381	Q13087
TPPVKSLEEDPWPRV	PPM1D	416	O15297
PKPKRWRVDEVEQSP	NPIPB7	361	O75200
ERKPKTEEFPSFIPW	OVOS2	1166	Q6IE36
IPAPAEAEAWSPRKL	IRAK1	121	P51617
EVSFEPPKWKAPRVL	OAS2	451	P29728
PKPKRWRVDEVEQSP	NPIPB15	356	A6NHN6
SIPPDVEEKLRLEWP	HPSE	131	Q9Y251
TAPEKWKRNPEDLPV	IL20RA	156	Q9UHF4
RTKTIDPQEPPWVEV	MYBBP1A	636	Q9BQG0
DPPASAKPLLRWDEV	PAQR9	36	Q6ZVX9
LECEEKVFPSPLWTP	PNOC	46	Q13519
LECKSDAVPPPVITW	HMCN1	3641	Q96RW7
VAQLVPIVPLEKAWP	NUTM1	166	Q86Y26
ADEIRLKWSPPEKPN	PTPRQ	721	Q9UMZ3
QEPEPVKPWKEVPNR	PPP1R3A	236	Q16821
PAAIIKPLEDQWVAP	OBSCN	2826	Q5VST9
VRVNSLDPAWPIKPL	PCF11	136	O94913
RVLGVPPPQIFWKKE	PALLD	1256	Q8WX93
PPPQIFWKKENESLT	PALLD	1261	Q8WX93
TPAPPIKRWELSSDQ	NDUFA7	96	O95182
VELDVWKGRPPEEEP	PLCB3	361	Q01970
ARIKNKAPSPDWPQE	ABCC5	1176	O15440
VSKSPLWPKENLDPV	NFASC	136	O94856
TDPPKDWPVVTLIAE	OTULIN	321	Q96BN8
QAQRLVKDWDPRTPP	CCDC105	476	Q8IYK2
LQPPKLWPESETEKE	CFAP119	231	A1A4V9
TKPEPQAPVAWERVA	C6orf132	936	Q5T0Z8
KRPFKWSEPSEPLEL	IGSF1	756	Q8N6C5
SLEIWVTDKPPKPSL	IGSF1	1151	Q8N6C5
PQPKETVVSRWRADP	KDM1A	741	O60341
EPDLKLVQPIPFFTW	CABIN1	256	Q9Y6J0
NPVPWEKEEYLKPVL	PRMT3	111	O60678
PDLWKLSPDQRKTSP	CHAMP1	446	Q96JM3
PESPWKVSPEEEQKR	DIS3L	451	Q8TF46
TKPASPLPEDLQRWV	UGT8	266	Q16880
NPAVWKNPKVFDPLR	CYP4X1	416	Q8N118
KPPIEREEHRLPFWL	GON4L	906	Q3T8J9
DWDERPKIPDPEAVK	CANX	286	P27824
IWKPRKIPNPDFFED	CANX	396	P27824
KEAKEPLWIRPDAPS	CBS	36	P35520
EPRPVFEKKPLVWEE	CATIP	281	Q7Z7H3
STKRPLQAPRWPIEC	AGBL2	171	Q5U5Z8
LKEEWQDEDFPIPLP	BNIP2	6	Q12982
QLDPRTVQLFWKPVP	CSF3R	346	Q99062
LCDTLRFPDWPIKDP	DNAJC13	1261	O75165
KEDAIAPRTLPWPKS	ESAM	286	Q96AP7
KKWTPPRSPFNLVQE	MBD4	436	O95243
EFLKVAVEPPWPLNR	ATAT1	241	Q5SQI0
SWEDKQKCELPRPPS	DGKD	951	Q16760
RALKQKIWPGIPSPE	EPOR	276	P19235
LDKWLLPRNPPSEDL	EPOR	371	P19235
WRVEKFDLVPVPTNL	GSN	71	P06396
EKESAWSPPPIEIRL	AHCTF1	2206	Q8WYP5
WETSKPLEPPSEFII	CDH8	141	P55286
DPKLPKQRDQSEPVW	CCDC168	6286	Q8NDH2
EVIPKTIRWTIPPET	CCDC168	7026	Q8NDH2
QKSRFPPIDKPWILS	FAM186A	2066	A6NE01
PASPKAEPIWELPTR	FHOD1	521	Q9Y613
PKWARQDFSKVVPPL	CDK2	241	P24941
LPFLIQDWPLSESKP	LINC01554	21	Q52M75
EDDWSKPLPPSERLE	DDX3Y	131	O15523
WKPEEPIEVIRPDIA	GPX8	181	Q8TED1
PQIPFVWKRPGEIVK	CAPN9	61	O14815
QKFPIQFVWKRPPEI	CAPN3	91	P20807
KRQPAFDPWKSPENI	CDKL5	751	O76039
EKPVTTWLDSKPVLP	SALL3	506	Q9BXA9
QAKWLKSPTTPIDPE	CAMSAP2	856	Q08AD1
RQKRDWVIPPINLPE	CDH2	156	P19022
VAIDVPVWVPKPSVD	CFAP74	796	Q9C0B2
TENGLWLKVEPLPPR	CYP4F22	516	Q6NT55
PKPKRWRVDEVEQSP	NPIPB9	376	F8W1W9
PWVTPTKEDKLELTP	TACR2	326	P21452
RQKRDWVIPPISCPE	CDH1	151	P12830
SPGPQEPEKEERRVW	CNTROB	586	Q8N137
PLVPPLSWENVTVDK	IL17RC	411	Q8NAC3
PVKLLPWSPEDIDTR	PNLIPRP2	41	P54317
TVLRPSWADPPQEKV	LRRN4	11	Q8WUT4
SWADPPQEKVPLFRV	LRRN4	16	Q8WUT4
WKQKELAPLPSAESP	NYNRIN	416	Q9P2P1
PSQWPPEDEKEVIRR	PKN3	11	Q6P5Z2
DPNQLRWKPFEIPKA	HGD	91	Q93099
APSWDPVALKLPERN	LAMA4	1436	Q16363
ITKEDDALWPPPDRV	MAGOHB	71	Q96A72
LDVSPPGAREEPWLK	SZT2	2896	Q5T011
PFRKEPDPWELQLQK	SPATA17	181	Q96L03
PDPWELQLQKAKPLT	SPATA17	186	Q96L03
EPDAVQVTWKPPLIQ	USH2A	2736	O75445
AERVDPALPLEKQPW	SHD	226	Q96IW2
EETPSRDWIKRSLPP	TMC3	946	Q7Z5M5
EAKTWASRPQVPEPR	SEPTIN4	51	O43236
EIDEKTWVLEPEKPP	FANCL	206	Q9NW38
APKPPLQFLVWPERE	FER1L5	1466	A0AVI2
LVKAESPEKPERTPW	MSX1	131	P28360
DSLPAFPLLEPKIQW	TAF1C	541	Q15572
QPPAPSEDIWKKFEL	MYC	41	P01106
SEDIWKKFELLPTPP	MYC	46	P01106
SLYKEELEPKWPTPE	POMGNT1	456	Q8WZA1
VLWTLVSKEPPAPAD	PNPLA5	261	Q7Z6Z6
VVNDVDLPPWAKKPE	NBEA	2461	Q8NFP9
DLPPWAKKPEDFVRI	NBEA	2466	Q8NFP9
KLWKDLQEPVVPDPD	HUS1	141	O60921
RPIPKVPDQTWVQCD	MORC4	416	Q8TE76
KPPLRWTNFDPLEFL	PTCH1	251	Q13635
PPPPLSSDEWEKVKQ	RNF32	101	Q9H0A6
RKPPVPLDWAEVQSQ	UBA2	276	Q9UBT2
VAKVREVSQPDWTPP	PDIA4	161	P13667
DWTPPPEVTLVLTKE	PDIA4	171	P13667
WTLPPEQLLPKEVLS	IARS2	566	Q9NSE4
WDPSIRIEPPKNVPS	SLC4A8	401	Q2Y0W8
IEPLKPEERKWDFPE	STARD9	1121	Q9P2P6
GDPPRTVLQAPKEWV	ESRP2	711	Q9H6T0
PEIFDPPEELERKVW	SIRT6	21	Q8N6T7
KPEFPRADGIVPETW	MRPL24	156	Q96A35
AEIEDPPIPEKPWKV	SMARCC1	251	Q92922
KQEEEVGWKLVPRPR	PLAGL2	16	Q9UPG8
KQLIEWDKPPVPGVD	SH3RF1	261	Q7Z6J0
RAKIPDPSAVKPEDW	CLGN	281	O14967
FKPAPECWIPAKETE	C12orf29	111	Q8N999
LERVLPQPPKSSEVW	CNGB1	166	Q14028
PDPTAEWKSVVILVP	ATG4D	291	Q86TL0
PDPALDEVRKEEWPL	PIK3CG	311	P48736
WPEIKVPRPDALDNE	RETREG3	111	Q86VR2
RWGPEEDKVELPPAE	SUGP1	386	Q8IWZ8
DKRRLFPPWIKPADT	PRPF8	931	Q6P2Q9
EVPAPPLLLQWVKTD	PLK3	556	Q9H4B4
FAVDIKVIKDLPWPP	SHF	216	Q7M4L6
PLKLERDCRSPVDPW	SH3BGR	11	P55822
EPVPEEKPKELPEWS	SPART	406	Q8N0X7
WLRQEEDIPPKVPQR	TNIK	661	Q9UKE5
VDKIWTDRPERPCKP	XPNPEP1	151	Q9NQW7
QSRSPPAVVEEKWKP	ZNF618	426	Q5T7W0
SWRKEQPRPDVPITD	ZC3H12A	181	Q5D1E8
DVILPPWAKGDPREF	WDFY3	2876	Q8IZQ1
PKEPPSWSLARDIVF	TRPM6	1001	Q9BX84
SEDIWKKFELVPSPP	MYCL	26	P12524
VREPPNAKPDWLKVG	NDUFC1	31	O43677
PAWIPVPARREAEKV	SHANK3	1166	Q9BYB0
LTLPPPKVVDRWNEK	MRPL51	36	Q4U2R6
PKVPEWNLIPSVAVD	SLC26A2	371	P50443
WVPKQKPLDPVLESV	TMOD1	96	P28289
EPPATVVKWNKDGRP	IGSF9B	351	Q9UPX0
PQDTVRIFPPWQKLI	SPIDR	356	Q14159
PEKELAPEPEETWVA	SPDYE3	356	A6NKU9
RPEPWELSLEEVLKA	SPIRE2	16	Q8WWL2
PVTRFPVPNEKVPWE	TRPM2	1251	O94759
PVPNEKVPWETEFLI	TRPM2	1256	O94759
EDPDSVPPIDVLWIK	SRXN1	71	Q9BYN0
RLPLKPSIWDEPEDL	ZSCAN1	206	Q8NBB4
VISQPEQKEEPWVLP	ZNF774	41	Q6NX45
EWDPSIRIEPPKNVP	SLC4A10	431	Q6U841
WREKLSPIPAVPASV	SPAG1	576	Q07617
EEPRKVLAPEPEEIW	SPDYE1	116	Q8NFV5
RPLEPTQDPLKWQRL	HEATR9	136	A2RTY3
RKSWPEPDQKPEPVD	UBL7	91	Q96S82
QERKVTPIDSPPVWS	PRRC2B	731	Q5JSZ5
LPWVPPDTKLSKLDT	TCF21	106	O43680
DGLSPWDPPVLIQKR	PREPL	281	Q4J6C6
AKEFKDPLLQEPPAW	TMEM97	51	Q5BJF2
EDPDWIKRLLQSPCP	GTF3C4	801	Q9UKN8
RPPEGVPAAEVEWLK	UNC5D	181	Q6UXZ4
VDWEAVPQRKLKPPI	PRKX	306	P51817
LDPAALSPANPREKW	PITPNM3	606	Q9BZ71
PKTIVLPPNWKTARD	SETD2	2386	Q9BYW2
LPPNWKTARDPEGKI	SETD2	2391	Q9BYW2
ILEDPKWEFPRKNLV	RET	711	P07949
QWKPPIEREEHRLPF	YY1AP1	361	Q9H869
PPQIDAVKRRTLPAW	PNISR	221	Q8TF01
PPNSVLPDKLKVSWE	PLEKHO2	261	Q8TD55
VDQGPSRDIPKPWVI	TTC16	11	Q8NEE8
KLIPWPLEEQFIPKG	WSB2	51	Q9NYS7
PLEPSQDEKSIPLIW	TREML1	151	Q86YW5
TVPWEQPATKDPLLR	TTYH3	331	Q9C0H2
DWDVVPPEKKPIFIQ	WDR87	1306	Q6ZQQ6
PPAPIEVWTDLAEKI	SNAPC2	96	Q13487
QTEEWKPQVIVLPIP	ZMYM3	856	Q14202
KKGVILPIWEPQDPS	SLC8A1	56	P32418
KWPSPPKVLRRFEEA	MYO1D	761	O94832